1.
Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2.
Research Methodology
2.1.
Objective of the Study
2.2.
Baseline Methodology
2.3.
Key Industry Partners
2.4.
Major Association and Secondary Sources
2.5.
Forecasting Methodology
2.6.
Data Triangulation & Validation
2.7.
Assumptions and Limitations
3.
Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4.
Voice of Customer
5.
Global Clinical Trial
Imaging Market Outlook
5.1. Market Size & Forecast
5.1.1.
By Value
5.2. Market Share & Forecast
5.2.1. By Product & Service (Trial
Design Consulting Services, Read Analysis Services, Operational Imaging
Services, Imaging Software)
5.2.2. By Modality
(Magnetic Resonance Imaging, Computed Tomography, Ultrasound, Positron Emission
Tomography, X-Ray, Echocardiography, Other Modalities)
5.2.3. By End-User
(Pharmaceutical & Biotechnology Companies, Medical Device Manufacturers,
Academic and Government Research Institute)
5.2.4. By
Region (North America, Europe, Asia Pacific, South America, Middle East &
Africa)
5.2.5. By
Company (2023)
5.3. Market Map
5.3.1 By Product & Service
5.3.2 By Modality
5.3.3 By End-User
5.3.4 By Region
6.
North America Clinical
Trial Imaging Market Outlook
6.1. Market Size & Forecast
6.1.1.
By Value
6.2. Market Share & Forecast
6.2.1. By Product & Service
6.2.2. By Modality
6.2.3. By End-User
6.2.4.
By Country
6.3. North America: Country Analysis
6.3.1.
United States Clinical
Trial Imaging Market Outlook
6.3.1.1.
Market Size & Forecast
6.3.1.1.1.
By Value
6.3.1.2.
Market Share & Forecast
6.3.1.2.1.
By Product &
Service
6.3.1.2.2.
By Modality
6.3.1.2.3.
By End-User
6.3.2.
Canada Clinical
Trial Imaging Market Outlook
6.3.2.1.
Market Size & Forecast
6.3.2.1.1.
By Value
6.3.2.2.
Market Share & Forecast
6.3.2.2.1.
By Product &
Service
6.3.2.2.2.
By Modality
6.3.2.2.3.
By End-User
6.3.3.
Mexico Clinical
Trial Imaging Market Outlook
6.3.3.1.
Market Size & Forecast
6.3.3.1.1.
By Value
6.3.3.2.
Market Share & Forecast
6.3.3.2.1.
By Product &
Service
6.3.3.2.2.
By Modality
6.3.3.2.3.
By End-User
7.
Europe Clinical
Trial Imaging Market Outlook
7.1. Market Size & Forecast
7.1.1.
By Value
7.2. Market Share & Forecast
7.2.1. By Product & Service
7.2.2. By
Modality
7.2.3. By End-User
7.2.4.
By Country
7.3. Europe: Country Analysis
7.3.1.
France Clinical
Trial Imaging Market Outlook
7.3.1.1.
Market Size & Forecast
7.3.1.1.1.
By Value
7.3.1.2.
Market Share & Forecast
7.3.1.2.1.
By Product &
Service
7.3.1.2.2.
By Modality
7.3.1.2.3.
By End-User
7.3.2.
Germany Clinical
Trial Imaging Market Outlook
7.3.2.1.
Market Size & Forecast
7.3.2.1.1.
By Value
7.3.2.2.
Market Share & Forecast
7.3.2.2.1.
By Product &
Service
7.3.2.2.2.
By Modality
7.3.2.2.3.
By End-User
7.3.3.
United Kingdom Clinical
Trial Imaging Market Outlook
7.3.3.1.
Market Size & Forecast
7.3.3.1.1.
By Value
7.3.3.2.
Market Share & Forecast
7.3.3.2.1.
By Product &
Service
7.3.3.2.2.
By Modality
7.3.3.2.3.
By End-User
7.3.4.
Italy Clinical Trial
Imaging Market Outlook
7.3.4.1.
Market Size & Forecast
7.3.4.1.1.
By Value
7.3.4.2.
Market Share & Forecast
7.3.4.2.1.
By Product &
Service
7.3.4.2.2.
By Modality
7.3.4.2.3.
By End-User
7.3.5.
Spain Clinical Trial
Imaging Market Outlook
7.3.5.1.
Market Size & Forecast
7.3.5.1.1.
By Value
7.3.5.2.
Market Share & Forecast
7.3.5.2.1.
By Product &
Service
7.3.5.2.2.
By Modality
7.3.5.2.3.
By End-User
8.
Asia-Pacific Clinical
Trial Imaging Market Outlook
8.1. Market Size & Forecast
8.1.1.
By Value
8.2. Market Share & Forecast
8.2.1.
By
Product & Service
8.2.2.
By
Modality
8.2.3.
By
End-User
8.2.4.
By
Country
8.3. Asia-Pacific: Country Analysis
8.3.1.
China Clinical Trial
Imaging Market Outlook
8.3.1.1.
Market Size & Forecast
8.3.1.1.1.
By Value
8.3.1.2.
Market Share & Forecast
8.3.1.2.1.
By Product &
Service
8.3.1.2.2.
By Modality
8.3.1.2.3.
By End-User
8.3.2.
India Clinical Trial
Imaging Market Outlook
8.3.2.1.
Market Size & Forecast
8.3.2.1.1.
By Value
8.3.2.2.
Market Share & Forecast
8.3.2.2.1.
By Product &
Service
8.3.2.2.2.
By Modality
8.3.2.2.3.
By End-User
8.3.3.
Japan Clinical Trial
Imaging Market Outlook
8.3.3.1.
Market Size & Forecast
8.3.3.1.1.
By Value
8.3.3.2.
Market Share & Forecast
8.3.3.2.1.
By Product &
Service
8.3.3.2.2.
By Modality
8.3.3.2.3.
By End-User
8.3.4.
South Korea Clinical
Trial Imaging Market Outlook
8.3.4.1.
Market Size & Forecast
8.3.4.1.1.
By Value
8.3.4.2.
Market Share & Forecast
8.3.4.2.1.
By Product &
Service
8.3.4.2.2.
By Modality
8.3.4.2.3.
By End-User
8.3.5.
Australia Clinical
Trial Imaging Market Outlook
8.3.5.1.
Market Size & Forecast
8.3.5.1.1.
By Value
8.3.5.2.
Market Share & Forecast
8.3.5.2.1.
By Product &
Service
8.3.5.2.2.
By Modality
8.3.5.2.3.
By End-User
9.
South America Clinical
Trial Imaging Market Outlook
9.1. Market Size & Forecast
9.1.1.
By Value
9.2. Market Share & Forecast
9.2.1. By Product & Service
9.2.2. By
Modality
9.2.3. By End-User
9.2.4.
By Country
9.3. South America: Country Analysis
9.3.1.
Brazil Clinical
Trial Imaging Market Outlook
9.3.1.1.
Market Size & Forecast
9.3.1.1.1.
By Value
9.3.1.2.
Market Share & Forecast
9.3.1.2.1.
By Product &
Service
9.3.1.2.2.
By Modality
9.3.1.2.3.
By End-User
9.3.2.
Argentina Clinical
Trial Imaging Market Outlook
9.3.2.1.
Market Size & Forecast
9.3.2.1.1.
By Value
9.3.2.2.
Market Share & Forecast
9.3.2.2.1.
By Product &
Service
9.3.2.2.2.
By Modality
9.3.2.2.3.
By End-User
9.3.3.
Colombia Clinical
Trial Imaging Market Outlook
9.3.3.1.
Market Size & Forecast
9.3.3.1.1.
By Value
9.3.3.2.
Market Share & Forecast
9.3.3.2.1.
By Product &
Service
9.3.3.2.2.
By Modality
9.3.3.2.3.
By End-User
10.
Middle East and
Africa Clinical Trial Imaging Market Outlook
10.1.
Market Size &
Forecast
10.1.1. By Value
10.2.
Market Share &
Forecast
10.2.1. By Product & Service
10.2.2. By
Modality
10.2.3. By End-User
10.2.4.
By Country
10.3.
MEA: Country
Analysis
10.3.1. South Africa Clinical Trial Imaging
Market Outlook
10.3.1.1.
Market Size & Forecast
10.3.1.1.1.
By Value
10.3.1.2.
Market Share & Forecast
10.3.1.2.1.
By Product &
Service
10.3.1.2.2.
By Modality
10.3.1.2.3.
By End-User
10.3.2. Saudi Arabia Clinical Trial Imaging
Market Outlook
10.3.2.1.
Market Size & Forecast
10.3.2.1.1.
By Value
10.3.2.2.
Market Share & Forecast
10.3.2.2.1.
By Product &
Service
10.3.2.2.2.
By Modality
10.3.2.2.3.
By End-User
10.3.3. UAE Clinical Trial Imaging Market Outlook
10.3.3.1.
Market Size & Forecast
10.3.3.1.1.
By Value
10.3.3.2.
Market Share & Forecast
10.3.3.2.1.
By Product &
Service
10.3.3.2.2.
By Modality
10.3.3.2.3.
By End-User
11. Market Dynamics
11.1.
Drivers
11.2.
Challenges
12. Market Trends & Developments
12.1.
Recent Development
12.2.
Mergers &
Acquisitions
12.3.
Product Launches
13.
Global Clinical Trial Imaging Market: SWOT Analysis
14.
Porter’s Five Forces Analysis
14.1.
Competition in the
Industry
14.2.
Potential of New
Entrants
14.3.
Power of Suppliers
14.4.
Power of Customers
14.5.
Threat of Substitute
Products
15. Competitive Landscape
15.1.
Clario Medical Imaging
Inc
15.1.1. Business Overview
15.1.2. Product Offerings
15.1.3. Recent Developments
15.1.4. Financials (As Reported)
15.1.5. Key Personnel
15.1.6. SWOT Analysis
15.2.
Icon PLC
15.3.
Ixico PLC
15.4.
Koninklijke Philips N.V
15.5.
Medpace
15.6.
Navitas Clinical
Research, Inc
15.7.
Parexel International
Corporation
15.8.
ProScan Imaging
15.9.
Radiant Sage LLC
15.10.
Resonance Health
16. Strategic Recommendations
17. About Us & Disclaimer